Novartis is investing more than 3.3 billion Chinese yuan (roughly $480 million) to soup up its manufacturing facility in Beijing and strengthen its R&D campus in Shanghai, where the company’s China headquarters are also located.
- Home |
- Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
- March 23, 2026
Recent Posts
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
- Cenovus to build oil sands business via Athabasca acquisition
- Centalion acquires Haynesville gas assets from Silver Hill
